What is AMGN's current stock price?

As of now, AMGN is trading at $364.65, with a daily change of -2.97%.

What are the risks associated with AMGN stock?

AMGN has Low, risk level based on volatility, sector strength, volume, investor confidence and outlook.

Market Overview Trending Stocks Stock Screener Trade Insights

Top Rated Stocks Most Active Stocks Top Potential Stocks Top Momentum Stocks Leaderboard

About Us Log In Sign Up Plans & Pricing Contact Us Terms of Use Privacy Policy

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist

AMGN Stock Analysis & IQ Rating | Amgen

AMGN

Amgen

$364.65

-$11.17 | -2.97%

Set Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Headlines

52W High

$385.12

MKT CAP

$198.52B

52W Low

$261.43

VOL

$3.47M

P/E Ratio

25.63

AVG VOL

$2.77M

RSI

59.80

TREND

Uptrend

AMGN Stock IQ

Login to see Amgen (AMGN) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

AMGN Target Price

Login to display

Strengths

AMGN Rewards

Earnings are forecast to grow

AMGN Rewards

Upgraded on attractively valued

AMGN Rewards

Outperform the market

AMGN Rewards

Trading below its fair value

AMGN Price Performance

$328.97 (+10.85%)

$336.74 (+8.29%)

$275.83 (+32.20%)

$305.82 (+19.24%)

1year

6month

3month

1month

AMGN Analysts Opinion

Overall standing based on market and analyst consensus. menu Hover over the category for more information

AMGN Analysts Opinion

AMGN Analysts opinion is positive and also has improved from the past 3 months

AMGN Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

86%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

100%

50%

100%

AMGN Street Sentiment

AMGN Street Sentiment is extremely bullish and have positive views on the near-term outlook

AMGN Risk Level

AMGN has Low risk level

Low

LOW

HIGH

AMGN Performance Sentiment

Sentiments overview associated with events and the stock performance

86%

14%

Positive

Negative

31 out of 36
events present

5 out of 36
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Key Price Levels

Average key support and resistance price levels

Support
Price

$367.67

Resistance
Price

$324.30

Current Price Range

$384.32

Show methods +

Analyst Consensus

Recent Upgrades and Downgrades

86%

Buy

Hold

Sell

Consensus Rating

STRONG BUY

6

1

0

Date

Action

Rating

Firm

Jan 29, 2026

Price Target Raised

Buy

UBS

Jan 06, 2026

Upgrade

Buy

UBS

Dec 04, 2025

Reiterate

Outperform

BMO Capital

Dec 03, 2025

Reiterate

Buy

Goldman Sachs

Nov 14, 2025

Reiterate

Overweight

Piper Sandler

AMGN Latest Analysis +

RBC Lifts Amgen (AMGN) Target After Strong Q4 Cites Key Drug Momentum. Amgen Inc. (NASDAQ:AMGN) is included among the 15 Best Wide Moat Dividend Stocks to Invest in. On February 4 RBC Capital raised its price recommendation on Amgen Inc. (NASDAQ:AMGN) to $360 from $335. The firm also kept an Outperform rating and pointed to a strong fourth quarter on both revenue and earnings. According to the [….]

Thu Feb 5, 2026

$367.80 | +0.44%

Activity

Earnings

Potential

These 2 Companies Could Soon Join the Weight Loss Market: Are They Buys?. Key PointsWeight loss candidates from Amgen and Roche performed well in phase 2 studies.

Thu Feb 5, 2026

$367.80 | +0.44%

Potential

Amgen (AMGN) Stock Hits 52-Week Highs: Buy Signal?. Amgen stock pushes to record highs following a strong earnings report. Is it a buy?

Wed Feb 4, 2026

$366.20 | +8.15%

Earnings

Technical

AMGNs Q4 Earnings & Sales Beat Estimates Obesity Candidate in Focus. Amgen delivers Q4 earnings and revenue beat driven by strong drug volumes as attention turns to its late-stage MariTide obesity studies.

Wed Feb 4, 2026

$366.20 | +8.15%

Earnings

Dow Movers: IBM AMGN. In early trading on Wednesday shares of Amgen topped the list of the days best performing Dow Jones Industrial Average components trading up 3.4%. Year to date Amgen registers a 6.9% gain.And the worst performing Dow component thus far on the day is International Business

Wed Feb 4, 2026

$366.20 | +8.15%

Momentum

Amgen (AMGN) Q4 Earnings and Revenues Beat Estimates. Amgen (AMGN) delivered earnings and revenue surprises of 11.18% and 4.23% respectively for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Tue Feb 3, 2026

$338.59 | -1.77%

Earnings

Heres What Key Metrics Tell Us About Amgen (AMGN) Q4 Earnings. Although the revenue and EPS for Amgen (AMGN) give a sense of how its business performed in the quarter ended December 2025 it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Tue Feb 3, 2026

$338.59 | -1.77%

Potential

Amgen beats on both lines in Q4 and issues 2026 guidance.

Tue Feb 3, 2026

$338.59 | -1.77%

Activity

Amgen Eyes Buy Zone After Fourth-Quarter Beat As Obesity Studies Mount. Amgen is running a number of studies of its obesity drug MariTide.The post Amgen Eyes Buy Zone After Fourth-Quarter Beat As Obesity Studies Mount appeared first on Investor'.s Business Daily.

Tue Feb 3, 2026

$338.59 | -1.77%

Earnings

Amgen Inc. Q4 Profit Rises . (RTTNews) - Amgen Inc. (AMGN) released earnings for its fourth quarter that Increases from the same period last year

Tue Feb 3, 2026

$338.59 | -1.77%

Earnings

Runners Also Watch

Close Price

Change

MRNA

Moderna

42.00

+0.11%

BIIB

Biogen

188.99

-2.49%

EXEL

Exelixis

42.98

-2.21%

CRSP

CRISPR Therapeutics

48.83

-1.75%

CHRS

Coherus BioSciences

2.11

+2.43%

FAQ About AMGN Stock Insights

What is AMGN current stock price?

What are AMGN stock strengths?

What is AMGN Risk Level?

What is AMGN market cap and volume?

What is AMGN current Stock IQ?

Should I buy AMGN stock right now?

Is AMGN a Strong Buy right now?

What does a 'Strong Buy' rating mean for AMGN?

What does a 'Strong Sell' rating mean for AMGN?

What factors influence AMGN's Stock IQ?

Explore our AMGN Stock insights

In-Depth Market Analysis and Trends
Expert Insights on Market Dynamics
Tailored AMGN Stock Strategies
Effective Risk Management

FIND US ON

Receive our AMGN Daily Alerts

Join over 5,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

AMGN

Amgen

Set Alerts

Current Price

$364.65

-$11.17 | -2.97%

52W High

$385.12

MKT CAP

$198.52B

52W Low

$261.43

VOL

$3.47M

P/E Ratio

25.63

AVG VOL

$2.77M

RSI

59.80

TREND

Uptrend

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Runners Also Watch

Symbol

Close

Change

MRNA

Moderna

42.00

+0.11%

BIIB

Biogen

188.99

-2.49%

EXEL

Exelixis

42.98

-2.21%

CRSP

CRISPR Therapeutics

48.83

-1.75%

CHRS

Coherus BioSciences

2.11

+2.43%

AMGN Price Performance

$328.97 (+10.85%)

$336.74 (+8.29%)

$275.83 (+32.20%)

$305.82 (+19.24%)

1year

6month

3month

1month

AMGN Analysts Opinion

Overall standing per market and analyst expectations. menu Hover over the category for more information

AMGN Analysts Opinion

AMGN Analysts opinion is positive and also has improved from the past 3 months

AMGN Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

86%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

100%

50%

100%

AMGN Street Sentiment

AMGN Street Sentiment is extremely bullish and have positive views on the near-term outlook

AMGN Risk Level

AMGN has Low risk level

Low

LOW

HIGH

AMGN Performance Sentiment

Sentiments overview associated with events and the stock performance.

86%

14%

Positive

Negative

31 out of 36
events present

5 out of 36
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Key Price Levels

Average key support and resistance price levels

Support
Price

$367.67

Resistance
Price

$324.30

Current Price Range

$384.32

Show methods +

Latest Analyst Actions

Overall Wall Street Rating

86%

Buy

Hold

Sell

Consensus Rating

STRONG BUY

6

1

0

Date

Action

Rating

Firm

Jan 29, 2026

Price Target Raised

Buy

UBS

Jan 06, 2026

Upgrade

Buy

UBS

Dec 04, 2025

Reiterate

Outperform

BMO Capital

Dec 03, 2025

Reiterate

Buy

Goldman Sachs

Nov 14, 2025

Reiterate

Overweight

Piper Sandler

AMGN Stock IQ

Login to unlock Amgen (AMGN) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

Target Price

Login to display

Stock Insights

Strengths

AMGN Rewards

Earnings are forecast to grow

AMGN Rewards

Upgraded on attractively valued

AMGN Rewards

Outperform the market

AMGN Rewards

Trading below its fair value

AMGN Latest Analysis

RBC Lifts Amgen (AMGN) Target After Strong Q4 Cites Key Drug Momentum. Amgen Inc. (NASDAQ:AMGN) is included among the 15 Best Wide Moat Dividend Stocks to Invest in. On February 4 RBC Capital raised its price recommendation on Amgen Inc. (NASDAQ:AMGN) to $360 from $335. The firm also kept an Outperform rating and pointed to a strong fourth quarter on both revenue and earnings. According to the [….]

Thu Feb 5, 2026

$367.80 | +0.44%

Activity

Earnings

Potential

These 2 Companies Could Soon Join the Weight Loss Market: Are They Buys?. Key PointsWeight loss candidates from Amgen and Roche performed well in phase 2 studies.

Thu Feb 5, 2026

$367.80 | +0.44%

Potential

Amgen (AMGN) Stock Hits 52-Week Highs: Buy Signal?. Amgen stock pushes to record highs following a strong earnings report. Is it a buy?

Wed Feb 4, 2026

$366.20 | +8.15%

Earnings

Technical

AMGNs Q4 Earnings & Sales Beat Estimates Obesity Candidate in Focus. Amgen delivers Q4 earnings and revenue beat driven by strong drug volumes as attention turns to its late-stage MariTide obesity studies.

Wed Feb 4, 2026

$366.20 | +8.15%

Earnings

Dow Movers: IBM AMGN. In early trading on Wednesday shares of Amgen topped the list of the days best performing Dow Jones Industrial Average components trading up 3.4%. Year to date Amgen registers a 6.9% gain.And the worst performing Dow component thus far on the day is International Business

Wed Feb 4, 2026

$366.20 | +8.15%

Momentum

Amgen (AMGN) Q4 Earnings and Revenues Beat Estimates. Amgen (AMGN) delivered earnings and revenue surprises of 11.18% and 4.23% respectively for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Tue Feb 3, 2026

$338.59 | -1.77%

Earnings

Heres What Key Metrics Tell Us About Amgen (AMGN) Q4 Earnings. Although the revenue and EPS for Amgen (AMGN) give a sense of how its business performed in the quarter ended December 2025 it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Tue Feb 3, 2026

$338.59 | -1.77%

Potential

Discover AMGN Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends and the future potential of AMGN. We're here to help you make informed investment decisions today.

FIND US ON

Receive our AMGN Daily Alerts

Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

AMGN Stock trends

AMGN Stock performance

AMGN Stock analysis

AMGN investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing AMGN

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing AMGN

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.

AMGN Stock Analysis & IQ Rating | Amgen

AMGN Stock IQ

AMGN Target Price

AMGN Analysts Opinion

AMGN Street Sentiment

AMGN Risk Level

AMGN Performance Sentiment

Key Price Levels

Analyst Consensus

Explore our AMGN Stock insights

Receive our AMGN Daily Alerts

AMGN Street Sentiment

AMGN Risk Level

Key Price Levels

Latest Analyst Actions

Discover AMGN Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends and the future potential of AMGN. We're here to help you make informed investment decisions today.

Receive our AMGN Daily Alerts

AMGN Alerts